Neuroscience, a sprawling scientific domain, encompasses the exhaustive study of the nervous system, spanning its structure, function, development, genetics, and pathology. Within this vast landscape lies neuroimmunology, a specialized branch delving into the intricate interactions between the nervous and immune systems, particularly in health and disease scenarios. This discipline scrutinizes how immune responses influence neural function and vice versa, shedding light on the underlying mechanisms of various neurological disorders. Researchers in neuroscience and neuroimmunology delve into phenomena like neuroinflammation, autoimmune diseases targeting the nervous system, neurodegenerative disorders, and the roles of immune cells in brain development and repair. Employing an interdisciplinary approach, they integrate techniques from immunology, molecular biology, genetics, and neuroscience to untangle the complexities of neuroimmune interactions. This understanding holds significant implications for developing innovative therapeutic strategies for neurological conditions. By targeting immune-mediated pathways, researchers aim to modulate neuroinflammatory processes, promote neuroprotection, and potentially halt disease progression in disorders such as multiple sclerosis, Alzheimer's, and Parkinson's.
Title : Atypical presentation of Juvenile myoclonic epilepsy in a 16-year-old female: A case report
George Diaz, Memorial Healthcare Systems, United States
Title : Triple-network dysfunction, ME/CFS, and the NeuroPhysics Treatment Process “A dynamical systems perspective on psychophysical organization and environmental interaction”
Ken Ware, NeuroPhysics Therapy Institute and Research Centre, Australia
Title : Beyond plaques: 10-nanometer-scale pathoconnectomics of Alzheimer’s disease
Ons M Saad, Panluminate Inc., United States
Title : Results from the global phase 3 trial (IB1001-303) evaluating levacetylleucine in children and adults with ataxia-telangiectasia
Chidinma Ejim, IntraBio, United States
Title : A phase 3, multinational, randomized, placebo-controlled, double-blind, crossover trial (IB1001-304) evaluating levacetylleucine in CACNA1A
Chidinma Ejim, IntraBio, United States
Title : Clinical and molecular phenotype of PTRHD1-associated juvenile parkinsonism
Bhavan A Modi, Barrow Neurological Institute at Phoenix Children's, United States